How CAR T Cell Therapy Works to Target and Destroy Cancer Cells



![]()




CAR T-cell therapy is an advanced form of immunotherapy that uses a patient’s own immune system to fight cancer.
Once infused back into the patient, CAR Tcells multiply in the body and actively seek out cancer cells.

They bind to specific antigens (commonly CD19 in blood cancers) and release toxic substances that kill the malignant cells. Unlike chemotherapy, which affects both healthy and cancerous cells, CAR T-cell therapy is targeted, reducing collateral damage and improving outcomes in certain resistant cancers.
1.Collection (Leukapheresis): T-cells are extracted from the patient’s blood.
2.Genetic Modification: In a lab, T-cells are engineered to express CAR proteins.
3.Cell Expansion: These modified cells are multiplied to millions in number.
4.Conditioning Therapy: The patient may receive mild chemotherapy to prepare the body.
5.Infusion: CAR T-cells are infused back into the bloodstream.
6.Monitoring: Patients are closely observed for response and side effects.

CAR T-cell therapy has shown remarkable success in certain blood cancers, especially in patients who have not responded to other treatments. Response rates in some leukemias and lymphomas can exceed 70–80%. However, it is not without risks. Common side effects include cytokine release syndrome (CRS)—causing fever and inflammation—and neurological symptoms such as confusion or headaches. These are usually manageable with timely medical care.
Currently, CAR T-cell therapy is approved mainly for B-cell acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), and some other lymphomas and multiple myeloma. Eligibility depends on factors like disease type, prior treatment response, overall health, and organ function. Not all patients qualify, making specialist evaluation essential.

Choosing the Best CAR T Cell Therapy Hospital in Chennai involves looking for centers with experienced hematologists, advanced lab facilities, and intensive care support. Since this is a highly specialized treatment, patients should seek accredited hospitals with proven expertise in cellular therapies and posttreatment monitoring.

